Weekly Recap: Veraxa Biotech (VRXA) NASDAQ debut and leadership hires

Veraxa Biotech AG (NASDAQ:VRXA) began Nasdaq trading after a June 2026 business combination and is advancing an oncology pipeline while seeking industrial partners for its platforms; new CFO Raju Willener and CSO Christoph Erkel, Ph.D., join to strengthen finance and antibody development.Previous W…